Healthcare

Consumer Drug Take-Back Milestone — Half A Million Pounds Collected!

Half a million pounds. It sounds like a lot, but how much is it? Half a million pounds is equivalent to two and a half blue whales, a 2,500 square foot home or a locomotive engine. That’s how much unwanted medication we’ve collected through the placement of 4,000 kiosks with the Consumer Drug Take-Back program.

• Read more about Consumer Drug Take-Back Milestone — Half A Million Pounds Collected!

Consumer Drug Take-Back — It's Not Only A Public Health Issue, It's Personal

This year, overdose deaths increased 30% in the US, reaching the highest rate in our country’s history. That means, on average, over 260 Americans die every day from a drug overdose, according to the CDC. This persistent (and increasing) problem demands new solutions. Inmar surveyed 1,000 adults across the US to understand how they’re personally impacted by prescription drug misuse, and to gauge their awareness of proper disposal options.

• Read more about Consumer Drug Take-Back — It's Not Only A Public Health Issue, It's Personal

The drug supply chain never stops. Neither do we.

At Inmar, we’re intimately involved in the drug supply chain; from delivering data and insights at a drug’s market entry to facilitating its final disposition. We’ve set out to simplify the complex -- throughout the drug journey -- to drive greater efficiency, reduce waste, ensure compliance and support sustainability.

• Read more about The drug supply chain never stops. Neither do we.

More time for patients is the sign of an Inmar client

For pharmacy managers operating in today’s rapidly evolving healthcare space, it seems there are more questions than answers.

• Read more about More time for patients is the sign of an Inmar client

A Fresh Look at the Problem of Prescription Drug Abuse

All those working in the industry of medications need to think about population health from an additional angle. This “new” vantage point should focus on the diversion and misuse of prescription medications, the growth of this problem and the impact it has on population health. 

• Read more about A Fresh Look at the Problem of Prescription Drug Abuse

RASMAS Is Now OneRecall

A product name change may not seem like important news but the innovation we’re bringing to recall processing is transforming how hospital pharmacies and pharma manufacturers protect themselves -- and their patients.  And that makes it important for everyone in the healthcare industry to know what’s happening.  Get all the news in this video from David Schweihs, our Vice President, Healthcare. RASMAS is now OneRecall  

• Read more about RASMAS Is Now OneRecall

Combating The Opioid Crisis In The Pharmacy

It’s happening again. Another pharmacy operator is facing federal prosecution for allegedly mismanaging prescription opioids and violating the Controlled Substances Act. And the civil penalties being sought by the Department of Justice could total in the billions of dollars.

• Read more about Combating The Opioid Crisis In The Pharmacy

Who’s Guiding You Through The Digital Transformation Of Healthcare?

Learn how Inmar is enabling this digital transformation -- helping healthcare organizations better protect patients, meet their regulatory responsibilities and mitigate risk throughout the drug supply chain.

• Read more about Who’s Guiding You Through The Digital Transformation Of Healthcare?

Without Insights and Information, Needed Improvement is Impossible

Inmar Intelligence has the pharmacy solutions for retail pharmacies to increase revenue.

• Read more about Without Insights and Information, Needed Improvement is Impossible